TERESA RIVERS: Open Payments
NPI 1386226736 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,719 in 129 payments from 16 companies in 2025. Trend: 2023 $573 · 2024 $2,578 · 2025 $2,719
Food & beverage: $2,719
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 20 | $534 |
| Alkermes, Inc. | 13 | $295 |
| Otsuka America Pharmaceutical, Inc. | 20 | $257 |
| Axsome Therapeutics, Inc. | 11 | $253 |
| Corium, LLC | 8 | $196 |
| Vanda Pharmaceuticals Inc. | 7 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $181 |
| ABBVIE INC. | 10 | $168 |
| Lundbeck LLC | 4 | $100 |
| E.R. Squibb & Sons, L.L.C. | 4 | $95 |
Products named: INGREZZA, REXULTI, LYBALVI, Azstarys, FANAPT, CAPLYTA, VRAYLAR, Sunosi.
Industry payments across TN — which companies pay providers there.
